loading

Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
0.64
- 0.346 0.988 2.679
Operating Expenses
18.37%
74.17
62.66 59.32 53.98 50.66
Benefits Costs and Expenses
100.00%
-
218.54 - - -
Costs And Expenses
35.89%
74.17
54.58 59.32 53.98 50.66
Depreciation and Amortization
80.92%
0.474
0.262 0.273 0.28 0.283
Operating Income/Loss
17.35%
-73.53
-62.66 -58.98 -52.99 -47.98
Nonoperating Income/Loss
4.54%
7.069
6.762 2.516 2.016 1.983
Income/Loss From Continuing Operations Before Tax
100.29%
0.64
-218.54 0.346 0.988 2.679
Income/Loss From Continuing Operations After Tax
11.37%
-66.93
-60.10 -57.46 -50.98 -45.99
Net Income/Loss
11.37%
-66.93
-60.10 -57.46 -50.98 -45.99
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,256%
72.29
3.068 56.81 54.27 53.91
Diluted Average Shares
2,256%
72.29
3.068 56.81 54.27 53.91
Basic Earnings Per Share
5.68%
-0.93
-0.88 -1.01 -0.94 -0.85
Diluted Earnings Per Share
5.68%
-0.93
-0.88 -1.01 -0.94 -0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):